# Study Of Angiomax In Infants Under Six Months With Thrombosis

> **NCT00043277** · PHASE2 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 25 (—)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** Angiomax (bivalirudin)

## Key facts

- **NCT ID:** NCT00043277
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 25 (—)
- **Last updated:** 2006-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043277, "Study Of Angiomax In Infants Under Six Months With Thrombosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00043277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*